Membranoproliferative glomerulonephritis diagnostic study of choice: Difference between revisions
No edit summary |
Aditya Ganti (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Membranoproliferative glomerulonephritis}} | |||
{{CMG}} ; {{AE}} | |||
==Overview== | ==Overview== | ||
Revision as of 17:04, 26 July 2018
|
Membranoproliferative glomerulonephritis Microchapters |
|
Differentiating Membranoproliferative glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Membranoproliferative glomerulonephritis diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Membranoproliferative glomerulonephritis diagnostic study of choice |
|
FDA on Membranoproliferative glomerulonephritis diagnostic study of choice |
|
CDC on Membranoproliferative glomerulonephritis diagnostic study of choice |
|
Membranoproliferative glomerulonephritis diagnostic study of choice in the news |
|
Blogs on Membranoproliferative glomerulonephritis diagnostic study of choice |
|
Directions to Hospitals Treating Membranoproliferative glomerulonephritis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief:
Overview
Diagnostic study of choice
Study of choice
- Renal biopsy is the gold standard diagnostic test for the diagnosis of membranoproilferative glomerulonephritis[1]19908070 .
- Light microscopy, electron dense microscopy and immunofluorescence are performed on the renal biopsy sample.
- Other tests include
- CBC,
- Urine analysis
- Renal function tests
- Serum ANA
- Serum complement profile
- Antistreptolysin-O titres
- Hepatits B and Hepatitis C
- Blood cultures
- Serum and urine electrophoresis[2]
- These tests must be performed when a patient presents with anorexia, malaise, edema, secondary hypertension and oliguria.
Diagnostic results
Light microscopy
- The findings of glomerulus with increased mesangial cellularity, increase in the mesangial matrix, and thickened peripheral capillary walls are confirmatory for the disease.
Electron microscopy
- Immune deposits in the mesangium and subendothelial space.
Immunoflourescence
- Presence of immunoglbulins or complement in the mesangium depending on the cause.
CBC
- Normocytic normochromic anemia
Urine analysis
- May show proteinuria
Renal function tests
- Serum creatinine and BUN might be elevated
Complement profile
- C3, C4 and CH50 levels for classic complement pathway
- AH50 levels for alternate complement pathway
- C3 nephritic factor levelsj[3]
Serum ANA
- Postive serum ANA means autoimmune disease etiology
Blood culture
- Chronic bacterial infections
Diagnostic criteria
There is no established diagnostic criteria for membranoproliferative glomerulonephritis
References
- ↑ Sethi S, Fervenza FC (2012). "Membranoproliferative glomerulonephritis--a new look at an old entity". N Engl J Med. 366 (12): 1119–31. doi:10.1056/NEJMra1108178. PMID 22435371.
- ↑ Bridoux F, Leung N, Hutchison CA, Touchard G, Sethi S, Fermand JP; et al. (2015). "Diagnosis of monoclonal gammopathy of renal significance". Kidney Int. 87 (4): 698–711. doi:10.1038/ki.2014.408. PMID 25607108.
- ↑ Bourke E, Campbell WG, Piper M, Check IJ (1989). "Hypocomplementemic proliferative glomerulonephritis with C3 nephritic-factor-like activity in multiple myeloma". Nephron. 52 (3): 231–7. doi:10.1159/000185648. PMID 2662048.